Your browser doesn't support javascript.
loading
Heart failure promotes multimorbidity through innate immune memory.
Nakayama, Yukiteru; Fujiu, Katsuhito; Oshima, Tsukasa; Matsuda, Jun; Sugita, Junichi; Matsubara, Takumi James; Liu, Yuxiang; Goto, Kohsaku; Kani, Kunihiro; Uchida, Ryoko; Takeda, Norifumi; Morita, Hiroyuki; Xiao, Yingda; Hayashi, Michiko; Maru, Yujin; Hasumi, Eriko; Kojima, Toshiya; Ishiguro, Soh; Kijima, Yusuke; Yachie, Nozomu; Yamazaki, Satoshi; Yamamoto, Ryo; Kudo, Fujimi; Nakanishi, Mio; Iwama, Atsushi; Fujiki, Ryoji; Kaneda, Atsushi; Ohara, Osamu; Nagai, Ryozo; Manabe, Ichiro; Komuro, Issei.
Afiliação
  • Nakayama Y; Department of Cardiovascular Medicine, University of Tokyo, Tokyo, Japan.
  • Fujiu K; Department of Cardiovascular Medicine, University of Tokyo, Tokyo, Japan.
  • Oshima T; Department of Advanced Cardiology, University of Tokyo, Tokyo, Japan.
  • Matsuda J; Department of Cardiovascular Medicine, University of Tokyo, Tokyo, Japan.
  • Sugita J; Department of Cardiovascular Medicine, University of Tokyo, Tokyo, Japan.
  • Matsubara TJ; Department of Cardiovascular Medicine, University of Tokyo, Tokyo, Japan.
  • Liu Y; Department of Cardiovascular Medicine, University of Tokyo, Tokyo, Japan.
  • Goto K; Department of Cardiovascular Medicine, University of Tokyo, Tokyo, Japan.
  • Kani K; Department of Cardiovascular Medicine, University of Tokyo, Tokyo, Japan.
  • Uchida R; Department of Cardiovascular Medicine, University of Tokyo, Tokyo, Japan.
  • Takeda N; Department of Cardiovascular Medicine, University of Tokyo, Tokyo, Japan.
  • Morita H; Department of Advanced Cardiology, University of Tokyo, Tokyo, Japan.
  • Xiao Y; Department of Cardiovascular Medicine, University of Tokyo, Tokyo, Japan.
  • Hayashi M; Department of Cardiovascular Medicine, University of Tokyo, Tokyo, Japan.
  • Maru Y; Department of Cardiovascular Medicine, University of Tokyo, Tokyo, Japan.
  • Hasumi E; Department of Cardiovascular Medicine, University of Tokyo, Tokyo, Japan.
  • Kojima T; Department of Cardiovascular Medicine, University of Tokyo, Tokyo, Japan.
  • Ishiguro S; Department of Cardiovascular Medicine, University of Tokyo, Tokyo, Japan.
  • Kijima Y; Department of Cardiovascular Medicine, University of Tokyo, Tokyo, Japan.
  • Yachie N; School of Biomedical Engineering, Faculty of Applied Science and Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Yamazaki S; School of Biomedical Engineering, Faculty of Applied Science and Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Yamamoto R; Aquatic Bioscience, Graduate School of Agricultural and Life Sciences, University of Tokyo, Tokyo, Japan.
  • Kudo F; School of Biomedical Engineering, Faculty of Applied Science and Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Nakanishi M; Synthetic Biology Division, Research Center for Advanced Science and Technology, University of Tokyo, Tokyo, Japan.
  • Iwama A; Division of Stem Cell Therapy, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Fujiki R; Laboratory of Stem Cell Therapy, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
  • Kaneda A; Institute for the Advanced Study of Human Biology, Kyoto University, Kyoto, Japan.
  • Ohara O; Department of Systems Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Nagai R; Department of Systems Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Manabe I; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Komuro I; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Sci Immunol ; 9(95): eade3814, 2024 May 24.
Article em En | MEDLINE | ID: mdl-38787963
ABSTRACT
Patients with heart failure (HF) often experience repeated acute decompensation and develop comorbidities such as chronic kidney disease and frailty syndrome. Although this suggests pathological interaction among comorbidities, the mechanisms linking them are poorly understood. Here, we identified alterations in hematopoietic stem cells (HSCs) as a critical driver of recurrent HF and associated comorbidities. Bone marrow transplantation from HF-experienced mice resulted in spontaneous cardiac dysfunction and fibrosis in recipient mice, as well as increased vulnerability to kidney and skeletal muscle insults. HF enhanced the capacity of HSCs to generate proinflammatory macrophages. In HF mice, global chromatin accessibility analysis and single-cell RNA-seq showed that transforming growth factor-ß (TGF-ß) signaling was suppressed in HSCs, which corresponded with repressed sympathetic nervous activity in bone marrow. Transplantation of bone marrow from mice in which TGF-ß signaling was inhibited similarly exacerbated cardiac dysfunction. Collectively, these results suggest that cardiac stress modulates the epigenome of HSCs, which in turn alters their capacity to generate cardiac macrophage subpopulations. This change in HSCs may be a common driver of repeated HF events and comorbidity by serving as a key carrier of "stress memory."
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Cardíaca / Imunidade Inata / Memória Imunológica / Camundongos Endogâmicos C57BL Limite: Animals Idioma: En Revista: Sci Immunol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Cardíaca / Imunidade Inata / Memória Imunológica / Camundongos Endogâmicos C57BL Limite: Animals Idioma: En Revista: Sci Immunol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão